Inogen Reports Wider Q1 Net Loss and Negative Adjusted EBITDA Despite Revenue Growth
Summary
Inogen Inc. reported a 3.4% increase in first-quarter revenue to $85.1 million, but experienced a significantly wider GAAP net loss of $8.3 million and a shift to negative Adjusted EBITDA of $1.4 million.
Key Events
-
Q1 Revenue Growth
Total revenue increased 3.4% year-over-year to $85.1 million for the three months ended March 31, 2026, primarily driven by higher international demand.
-
Wider Net Loss
GAAP net loss significantly widened to $8.3 million, compared to $6.2 million in the prior year, reflecting increased operating expenses.
-
Negative Adjusted EBITDA
Adjusted EBITDA turned negative at $(1.4) million, a notable decline from a positive $0.036 million in the same period last year.
-
Cash Position Decline
Cash and cash equivalents decreased to $93.1 million as of March 31, 2026, from $103.7 million at December 31, 2025.
Analysis
Inogen Inc.'s first-quarter results present a mixed financial picture. While the company achieved a modest 3.4% year-over-year revenue growth, primarily driven by international sales, its profitability metrics deteriorated significantly. The GAAP net loss widened by 34.8%, and Adjusted EBITDA turned negative, indicating ongoing operational challenges despite increased sales. The decrease in cash and cash equivalents highlights a continued cash burn, which investors will closely monitor. Although the company initiated a share repurchase program, the operational losses are a more dominant factor in this quarter's performance.
At the time of this filing, INGN was trading at $7.02 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $191.8M. The 52-week trading range was $5.34 to $9.13. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.